Related references
Note: Only part of the references are listed.An open-label, 6-month study of allopurinol safety in gout: The LASSO study
Michael A. Becker et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
Pharmacokinetics, pharmacodynamics, and safety of lesinurad, a selective uric acid reabsorption inhibitor, in healthy adult males
Zancong Shen et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout
Fernando Perez-Ruiz et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Uricosuric drugs: the once and future therapy for hyperuricemia?
Mary H. Bach et al.
CURRENT OPINION IN RHEUMATOLOGY (2014)
Improving cardiovascular and renal outcomes in gout: what should we target?
Pascal Richette et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
Optimizing current treatment of gout
Frances Rees et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia
Roy Fleischmann et al.
RHEUMATOLOGY (2014)
Randomized Controlled Trial of Febuxostat Versus Allopurinol or Placebo in Individuals with Higher Urinary Uric Acid Excretion and Calcium Stones
David S. Goldfarb et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality
David Gustafsson et al.
BMC NEPHROLOGY (2013)
Renal Transport of Uric Acid: Evolving Concepts and Uncertainties
Alexandru Bobulescu et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2012)
2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
Dinesh Khanna et al.
ARTHRITIS CARE & RESEARCH (2012)
Risk Factors Associated With Renal Lithiasis During Uricosuric Treatment of Hyperuricemia in Patients With Gout
Fernando Perez-Ruiz et al.
ARTHRITIS CARE & RESEARCH (2010)
The urate-lowering Efficacy and Safety of Febuxostat in the Treatment Hyperuricemia of Gout: The CONFIRMS trial
C. Dejaco et al.
JOURNAL FUR MINERALSTOFFWECHSEL (2010)
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
Michael A. Becker et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study
H. R. Schumacher et al.
RHEUMATOLOGY (2009)
Febuxostat: a new treatment for hyperuricaemia in gout
N. Lawrence Edwards
RHEUMATOLOGY (2009)
Effects of Febuxostat Versus Allopurinol and Placebo in Reducing Serum Urate in Subjects With Hyperuricemia and Gout: A 28-Week, Phase III, Randomized, Double-Blind, Parallel-Group Trial
H. Ralph Schumacher et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Analytical approaches to reporting long-term clinical trial data
Kim A. Papp et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
Ravindra L. Mehta et al.
CRITICAL CARE (2007)
EULAR evidence based recommendations for gout.: Part II:: Management.: Report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT)
W. Zhang et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Therapeutic effects of xanthine oxidase inhibitors: Renaissance half a century after the discovery of allopurinol
P Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
Febuxostat compared with allopurinol in patients with hyperuricemia and gout
MA Becker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group
R Bellomo et al.
CRITICAL CARE (2004)
Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib
WB White et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Share Paper
